Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for INO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
June 30, 2026 36.67M
March 31, 2026 37.68M
December 31, 2025 58.51M
September 30, 2025 50.80M
June 30, 2025 47.55M
March 31, 2025 68.36M
December 31, 2024 94.11M
September 30, 2024 84.80M
June 30, 2024 110.42M
March 31, 2024 105.61M
December 31, 2023 145.29M
September 30, 2023 167.47M
June 30, 2023 194.93M
March 31, 2023 223.75M
December 31, 2022 253.00M
September 30, 2022 281.88M
June 30, 2022 348.13M
March 31, 2022 360.39M
December 31, 2021 401.31M
September 30, 2021 394.94M
June 30, 2021 443.68M
March 31, 2021 518.60M
December 31, 2020 411.64M
September 30, 2020 337.24M
June 30, 2020 371.66M
Date Value
March 31, 2020 270.00M
December 31, 2019 89.53M
September 30, 2019 93.80M
June 30, 2019 105.97M
March 31, 2019 128.00M
December 31, 2018 81.23M
September 30, 2018 85.49M
June 30, 2018 95.60M
March 31, 2018 112.77M
December 31, 2017 127.43M
September 30, 2017 141.89M
June 30, 2017 92.00M
March 31, 2017 89.66M
December 31, 2016 104.77M
September 30, 2016 119.69M
June 30, 2016 134.53M
March 31, 2016 146.79M
December 31, 2015 162.99M
September 30, 2015 170.78M
June 30, 2015 154.59M
March 31, 2015 81.01M
December 31, 2014 93.62M
September 30, 2014 100.93M
June 30, 2014 108.86M
March 31, 2014 116.78M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Fortress Biotech, Inc. 196.58M
Tonix Pharmaceuticals Holding Corp. 176.23M
Kura Oncology, Inc. 519.02M
Spero Therapeutics, Inc. 50.77M
ACADIA Pharmaceuticals, Inc. 956.47M